Identification of new inhibitors of the Toxoplasma gondii by using in-silico drug repurposing
Mosleh Kadkhodamohammadi, Milad Jaberi, Reza Babaei akerdi, Masoud Aliyar
This study identifies FDA-approved drugs that can inhibit Toxoplasma gondii's Calcium-Dependent Protein Kinase 1 through in-silico methods, suggesting potential new treatments for toxoplasmosis.
bioRxiv · Aug 13, 2019 · PreprintBioinformatics